The Canadian Medical Marijuana Association

12/19/2025

If pigs could fly I said,...
well, Im gonna hafta go throw some Bacon in the air,..lol..
Let the Age of Ma*****na ascend

11/07/2025

This week we had 2 or 3 old aresholes spouting off in their dementia which was amusing at best.. a pain in the arse at worst, lmao, from washouts, who never pulled their weight ONCE, beakin off like spoiled kids, over semantics, what a bunch of losers lolol

11/07/2025

11/07/2025

Heres a short clip from the documentary "Ride with Larry" which shows retired policeman Larry Smith, who suffers from Parkinson's, trying medical ma*****na for the first time, complete with results,.. MEDICAL Ma*****na is a most beneficial complementary treatment regime for Parkinsons . *****na

10/05/2025

THE BUZZ IS TOO BIG
Health Canada has issued a recall for Wintermint Chillows and Cinnamon Chillows cannabis gummies sold in Alberta, British Columbia, Manitoba, and Ontario due to inaccurate THC levels listed on the packaging. The pouches contain more than 10 mg of THC, with significant variability between units, which may lead to over-intoxication and temporary adverse effects such as confusion, disorganized thinking, physical and mental impairment, anxiety, panic, decreased blood pressure, and elevated heart rate. The recall alert advises that the higher and inconsistent THC levels could make it challenging to use the product safely.

09/29/2025

USA championed by Trump s makin Big Moves for CBD and Cannabis.. Well, well

09/16/2025

History and Founding The CMMA was established in 1998 by Thomas Messenger, a Canadian musician, disability advocate, and activist of Mi'kmaq heritage. At the time, medical ma*****na was illegal in Canada, and the organization aimed to advocate for patient rights, education, and legal access for those with chronic conditions or disabilities.
Messenger has publicly claimed credit for founding it and has used it to highlight personal and collective struggles against government and media suppression of medical cannabis advocacy. For instance, in social media posts as recent as 2025, he references the CMMA's role in pushing for legalization amid censorship and legal challenges.

Purpose and Activities The primary goal was to assist medical ma*****na patients by providing resources, community support, and advocacy to influence policy. It operated in the pre-legalization era (before Canada's 2001 Ma*****na Medical Access Regulations and full recreational legalization in 2018), helping patients navigate legal risks and connect with like-minded individuals.
Activities included awareness campaigns, protests, and education on the benefits of cannabis for pain management, disabilities, and other health issues. Messenger has described it as a vehicle for translating "morality into consequence" through activism, drawing parallels to broader social justice efforts.
It's distinct from larger bodies like the Canadian Medical Association (CMA), which is a professional organization for physicians that has issued policies on cannabis but is not patient-focused advocacy. Searches often confuse the two due to similar naming, but the CMMA is specifically for medical ma*****na patients and reform.

Current Status There's limited public information on an active official website or large-scale operations today, suggesting it may have been more prominent in the 1990s–2000s and could now be informal or dormant post-legalization. Messenger continues to reference it on platforms like X (formerly Twitter) in discussions about activism, censorship, and cannabis policy.
No major recent news articles or official records (e.g., from Health Canada) highlight ongoing activities, but it played a role in early advocacy that contributed to Canada's eventual medical and recreational frameworks.

Context in Canadian Cannabis Landscape The CMMA emerged during a pivotal period: Canada's medical cannabis program began in 2001, expanded in 2014, and recreational use was legalized in 2018 via the Cannabis Act. Organizations like the CMMA helped build momentum for these changes by amplifying patient voices.

08/26/2025

Understanding Live Resin:
A Concise Guide
Live resin is a premium cannabis concentrate prized for its rich flavor, aroma, and potency, offering a unique experience for medical and recreational users. Unlike traditional concentrates made from cured and dried cannabis, live resin is crafted from freshly harvested plants that are flash-frozen immediately after cutting. This preserves the plant’s terpenes—aromatic compounds responsible for taste and therapeutic effects—resulting in a product that closely mirrors the live cannabis flower.
Production Process
The process begins with freezing the cannabis within hours of harvest to lock in its natural compounds. The frozen material is then subjected to hydrocarbon extraction (using solvents like butane or propane), which extracts cannabinoids and terpenes at low temperatures. This cold extraction minimizes terpene loss, yielding a sticky, amber-colored resin. The final product can be used as a dab, v**e, or additive to other cannabis products.
Benefits
Live resin stands out for its full-spectrum profile, combining high THC levels (often 70-90%) with a robust terpene content. This enhances its entourage effect, where cannabinoids and terpenes work synergistically to boost therapeutic benefits like pain relief, anxiety reduction, and anti-inflammatory effects. Its fresh, complex flavors—ranging from fruity to earthy—also elevate the user experience compared to drier concentrates.
Considerations
The quality depends heavily on the strain and extraction technique, making premium live resin more expensive. Potential risks include residual solvents if not properly purged, though reputable producers adhere to strict safety standards. Users should start with small doses due to its potency.
Conclusion
Live resin represents a cutting-edge evolution in cannabis concentrates, offering a potent and flavorful option for those seeking maximum therapeutic and sensory benefits. As of August 2025, its popularity continues to grow, reflecting advancements in extraction technology and consumer demand for high-quality cannabis products.

08/21/2025

________________ THE BUD REPORT _________
Latest News on Ma*****na in Canada (2025)
Industry Growth and Financial Moves:
Sales Growth:
Cannabis retail sales in Canada hit a new high in May 2025, reaching C$485.4 million, up 4.0% from April’s C$466.7 million. This growth reflects a maturing legal market, with Statistics Canada noting steady increases in 2025.
Company Updates:
Major players like Aurora Cannabis reported strong Q2 2025 results, with net revenue of $127.3 million and positive cash flow. Auxly Cannabis Group completed debt-reduction transactions to strengthen its financial position, while TerrAscend exited Michigan but secured $79 million in debt financing.
Alberta’s Push:
Alberta launched the “Proudly Alberta” program in August 2025 to promote locally grown and made cannabis, aiming to boost regional producers.
Regulatory and Policy Developments:
Retail Changes:
Ontario is loosening strict rules requiring cannabis stores to cover windows, a change expected to improve safety and attract more customers. Calgary is considering allowing cannabis sales at events for attendees 18+, signaling evolving local regulations.
Indigenous Communities:
Mi’kmaq communities in Nova Scotia gained approval to open legal cannabis retail on reserves, expanding access. However, Kanehsatà:ke faces challenges with unregulated cannabis megastores, sparking environmental and governance concerns due to a construction boom along Route 344.
Federal Review:
The federal government initiated a Red Tape Review in 2025, which could ease regulations for the cannabis industry, following lobbying efforts to streamline licensing and compliance.
Public Health and Safety:
Cannabis Use Trends:
The 2024 Canadian Cannabis Survey (data collected April–July 2024) shows 27% of Canadians aged 16+ used cannabis in the past year, up from 25% in 2021. Usage is highest among 20–24-year-olds (50%) and in provinces like British Columbia and Ontario.
Health Concerns:
A 2025 study linked high cannabis use to increased mortality in colon cancer patients. Accidental pediatric cannabis poisonings remain a concern, with Health Canada emphasizing secure storage and public education campaigns to prevent “copycat” edible incidents.
Impaired Driving:
A 2025 focus on detecting cannabis-impaired drivers highlights ongoing public safety efforts, with new tech and policies under discussion to address rising traffic-related cannabis incidents.
International and Illicit Market Dynamics:Exports: Canadian medical cannabis exports to Germany are surging, though a new German bill may restrict this growth. Canopy Growth expanded its 7ACRES brand to Australia’s medical market in 2025.
Illicit Market:
Legal cannabis is outpacing the black market, with legal sales surpassing illegal ones since 2020. However, the Canada Border Services Agency seized over 160 kg of illegal cannabis at Calgary International Airport in 2025, showing enforcement challenges persist.
Global Context:
Canada’s legal market is viewed critically as other countries (e.g., Switzerland, Netherlands) explore legalization. A 2025 McGill study suggests higher legal prices and stricter enforcement could further reduce the illicit market but may increase consumption.
Sentiment and Trends
Industry Optimism:
The cannabis sector is seen as a growing economic contributor, with rising GDP impact despite broader agricultural declines. Companies like Organigram reported record revenues ($102.8 million in Q2 2025), fueling optimism.
Public Health Debate:
While legalization enjoys 64% public support, concerns about youth access, edibles, and impaired driving persist, especially after a 475% surge in Ontario’s cannabis-related traffic injuries over 11 years.
Social Media Buzz:
Sentiment on platforms reflects mixed views—some praise legalization’s economic benefits, while others criticize public health risks or regulatory gaps, particularly in Indigenous communities like Kanehsatà:ke.